NCT00527761 - Taxotere/Temodar/Cisplatin Study in Melanoma Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Metastatic Melanoma

Interventions

DRUG

Cisplatin

20 mg in 500 ml of normal saline by vein over 60 minutes daily for 4 days starting on day 1 of chemotherapy.

DRUG

Docetaxel

Starting dose 20 mg by vein over 1 hour, once a week, for three weeks (on Days 1, 8, and 15).

DRUG

Temodar

150 mg by mouth (PO) on Days 1 - 5.

Trial Locations (1)

U.T.M.D. Anderson Cancer Center, Houston